B. Riley lowered the firm’s price target on Abacus Life to $15 from $16 and keeps a Buy rating on the shares. The company’s capital arose pricing came in lower than modeled, the analyst tells investors in a research note. The firm adjusted its model for more shares and lesser debt capital.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ABL: